Schizophrenia Treatments

There is no cure for schizophrenia! The best we can achieve with treatment is to reduce and control the symptoms of schizophrenia.


The response to the treatment depends on:

The antipsychotic medication can be separated in classic and new class of antipsychotics.

Classic antipsychotics are the first that appeared and have been used. When they appeared it was thought that cure was found for schizophrenia because many symptoms disappeared or diminish. But that was not quite so. Chlorpromazine (Thorazine), haloperidol (Hadol) and thioridazine (Melarill) became the standard treatments in 1950s. This medication reduced very well hallucinations and delusions. But they have many side effects, some of them disappear after stopping the treatment, some of them irreversible, and that made the patient stop taking his medication.

The most important side effects of the classic antipsychotic are: dizziness, dry mouth, constipation, urinary retention, sexual problems, heart palpitation, blurred vision, muscle twitches, tics and akathisia.

In 1990s, appeared a new class of antipsychotics: Risperidone (Risperdal), olanzapine (Zyprexa), quetiapine (Seroquel), ziprasidone (Geodon) and aripiprazole (Abilify) and Clorazin acting at the brain level by blocking dopamine. This drugs don’t have the side effects that classic antipsychotic do.

The problems with the new antipsychotic medicine are:

Also, the new antipsychotic are a better alternative to the classic ones, and

patients are responding very well to this treatment.

Not only drug therapy is used. Also, group therapy, family therapy and individual psychotherapy are used with great results, and help the patient to a better integration in society.

Schizophrenia Treatment - Google News
Last update: 12/01/2008

Impact of schizophrenia and schizophrenia treatment-related ...
7thSpace Interactive (press release), NY - Nov 28, 2008
Conclusions: Events associated with schizophrenia and treatment of schizophrenia can bring about a significant detriment in patient quality of life, ...

Alkermes Regains Full Commercialization Rights to VIVITROL(R) in US
MarketWatch - 3 hours ago
... CONSTA(R) for schizophrenia. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, ...

Trial for novel schizophrenia treatment
Pharmacy Europe, UK - Nov 26, 2008
Lundbeck has initiated phase II trials with the compound Lu AE58054 for the treatment of schizophrenia. Lu AE58054 has shown positive results in a number of ...
Lundbeck initiates schizophrenia studies Hays Pharma
all 2 news articles

Experimental Drug May Address Working Memory Impairments That ...
Science Daily (press release) - 10 minutes ago
The study breaks new ground in the strategy used to develop new pharmacological treatments for schizophrenia, explained David Lewis, MD, UPMC Endowed Chair ...

Chicago Daily Herald

Grant aims to help Alexian Brothers improve autism treatment
Chicago Daily Herald, IL - 10 hours ago
Alexian's MEG Center is also being used for pioneering research into dementia, depression, schizophrenia, stroke, learning disorders, attention deficit, ...